-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation